Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Helix BioPharma Corp. (T.HBP) had Stock-Based Compensation of 0.11M for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
-1.09M |
|
-- |
|
-- |
|
-- |
|
-1.09M |
|
-- |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
-1.09M |
|
53.04M |
|
53.04M |
|
-0.02 |
|
-0.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.71M |
|
-- |
|
-- |
|
-- |
|
1.69M |
|
-0.98M |
|
-0.98M |
|
-0.98M |
|
53.15M |
|
| Cash Flow Statement Financials | |
-2.24M |
|
0.01M |
|
1.97M |
|
0.76M |
|
0.50M |
|
-0.26M |
|
|
Stock-Based Compensation |
0.11M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
111.08% |
|
111.08% |
|
-153.02% |
|
111.08% |
|
-0.03 |
|
-0.04 |
|
-0.04 |
|